Clinical Trials
4 trialsNCT01451853 2026-06-03
SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Sound Pharmaceuticals, Incorporated
Phase 2 Withdrawn
NCT06517888 2026-04-06
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
Akouos, Inc.
Phase 1/2 Recruiting
NCT04262336 2023-07-06
Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment
Decibel Therapeutics
Phase 1 Completed
NCT01452607 2016-06-29
Study to Evaluate the Safety and Pharmacokinetics of SPI-1005
Sound Pharmaceuticals, Incorporated
Phase 1 Completed